{"id":"placebo-of-hydrocortisone-plus-fludrocortisone","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Fatigue"},{"rate":"5-10%","effect":"Edema"},{"rate":"5-10%","effect":"Hypertension"}]},"_chembl":{"chemblId":"CHEMBL2106309","moleculeType":"Small molecule","molecularWeight":"460.57"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Hydrocortisone and fludrocortisone are corticosteroids that help replace the body's natural corticosteroids when they are deficient. This can help alleviate symptoms of adrenal insufficiency, such as fatigue, weight loss, and low blood pressure.","oneSentence":"This combination of hydrocortisone and fludrocortisone works by replacing deficient corticosteroids in the body.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:51:33.704Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Primary and secondary adrenal insufficiency"}]},"trialDetails":[{"nctId":"NCT07451886","phase":"PHASE2","title":"Adjunctive Fludrocortisone in Septic Shock","status":"NOT_YET_RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2026-04-01","conditions":"Sepsis, Septic Shock, Sepsis - to Reduce Mortality in the Intensive Care Unit","enrollment":32},{"nctId":"NCT06409364","phase":"PHASE2","title":"FLudrocortisone Administration in Aneurysmal Subarachnoid Haemorrhage","status":"RECRUITING","sponsor":"The George Institute","startDate":"2025-08-13","conditions":"Aneurysmal Subarachnoid Hemorrhage","enrollment":524},{"nctId":"NCT04280497","phase":"NA","title":"Rapid Recognition of Corticosteroid Resistant or Sensitive Sepsis","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2020-04-10","conditions":"Sepsis","enrollment":1800},{"nctId":"NCT07037043","phase":"PHASE3","title":"Hydrocortisone Plus Fludrocortisone in High-risk Patients Undergoing for Cardiac Surgery","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2025-08","conditions":"Inflammation in Cardiac Surgery","enrollment":196},{"nctId":"NCT05310253","phase":"NA","title":"Stress & Social Cognition in BPD (part 2)","status":"COMPLETED","sponsor":"Charite University, Berlin, Germany","startDate":"2022-02-01","conditions":"Borderline Personality Disorder","enrollment":240},{"nctId":"NCT03773822","phase":"PHASE3","title":"Low Dose of Hydrocortisone and Fludrocortisone in Adult Cardiogenic Shock.","status":"COMPLETED","sponsor":"CMC Ambroise Paré","startDate":"2019-04-19","conditions":"Cardiogenic Shock","enrollment":380},{"nctId":"NCT04128137","phase":"PHASE4","title":"Efficacy and Tolerance of Flucortac in Patients With Orthostatic Neurogenic Hypotension","status":"UNKNOWN","sponsor":"H.A.C. PHARMA","startDate":"2020-07-09","conditions":"Neurogenic Orthostatic Hypotension","enrollment":90},{"nctId":"NCT03548246","phase":"PHASE2","title":"Androgen Reduction in Congenital Adrenal Hyperplasia","status":"WITHDRAWN","sponsor":"University of Texas Southwestern Medical Center","startDate":"2023-01","conditions":"Congenital Adrenal Hyperplasia","enrollment":""},{"nctId":"NCT03062150","phase":"NA","title":"Mineralocorticoid Receptor, NMDA Receptor and Cognitive Function in Depression","status":"COMPLETED","sponsor":"Charite University, Berlin, Germany","startDate":"2016-09-27","conditions":"Major Depression","enrollment":232},{"nctId":"NCT01093261","phase":"PHASE3","title":"Corticosteroid Therapy for Glucocorticoid Insufficiency Related to Traumatic Brain Injury","status":"COMPLETED","sponsor":"Nantes University Hospital","startDate":"2010-08","conditions":"Traumatic Brain Injury, Trauma, Adrenal Insufficiency","enrollment":336},{"nctId":"NCT00625209","phase":"PHASE3","title":"Activated Protein C and Corticosteroids for Human Septic Shock","status":"COMPLETED","sponsor":"University of Versailles","startDate":"2008-03","conditions":"Septic Shock","enrollment":1241},{"nctId":"NCT00673270","phase":"PHASE1, PHASE2","title":"Effects of Fludrocortisone and Hydrocortisone in Healthy Volunteers With Aldosterone Induced Suppression","status":"TERMINATED","sponsor":"Rennes University Hospital","startDate":"2008-05","conditions":"Renin Angiotensin","enrollment":13},{"nctId":"NCT00368381","phase":"PHASE4","title":"Hydrocortisone Versus Hydrocortisone Plus Fludrocortisone for the Treatment of Adrenal Insufficiency in Severe Sepsis","status":"WITHDRAWN","sponsor":"CAMC Health System","startDate":"2006-09","conditions":"Sepsis, Adrenal Insufficiency","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":10,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"placebo of hydrocortisone plus fludrocortisone","genericName":"placebo of hydrocortisone plus fludrocortisone","companyName":"Centre Hospitalier Universitaire, Amiens","companyId":"centre-hospitalier-universitaire-amiens","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This combination of hydrocortisone and fludrocortisone works by replacing deficient corticosteroids in the body. Used for Primary and secondary adrenal insufficiency.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}